-
-
-
-
-
-
-
Vir Biotechnology announces collaboration with Astellas for VIR-5500
-
-
-
-
-
-
-
Vir Biotechnology reports positive hepatitis delta trial data
-
-
-
-
-
-
-
Vir Biotechnology to Provide Corporate Update and Report Second Quarter 2025 Financial Results on August 6, 2025
-
-
-
-
-
-
-
Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
-
-
-
-
-
-
-
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
-
-
-
-
-
-
-
Vir Biotechnology Inc. (VIR) Tops Q1 EPS by 57c
-
-
-
-
-
-
-
Vir Biotechnology Inc. (VIR) Misses Q3 EPS by 1c
-
1,207,990 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

